Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Carisma Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Carisma Therapeutics Inc market cap is $20,923.00.
What is the 52-week high for Carisma Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Carisma Therapeutics Inc 52 week high is $1.27 as of May 04, 2026.
What is the 52-week low for Carisma Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Carisma Therapeutics Inc 52 week low is $0.0001 as of May 04, 2026.
What is Carisma Therapeutics Inc stock price today?
Carisma Therapeutics Inc stock price today is $0.0005.
What was Carisma Therapeutics Inc stock price yesterday?
Carisma Therapeutics Inc stock price yesterday was $0.0005.
What is the Price-to-Book ratio of Carisma Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Carisma Therapeutics Inc P/B ratio is -0.0241.
What is the 50-day moving average of Carisma Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Carisma Therapeutics Inc 50-day moving average is $0.0296.